Nabi is a heavily shorted stock, which has a short ratio of 21 and 14% of the float shorted. Nabi makes and sells products to help with transplantation, infectious disease, nicotine addiction and hematology. The stock has negative earnings and a P/S of 2. The stock happens to be owned by the Los Angeles-based activist hedge fund, Chapman Capital , run by Bob Chapman. His hedge fund, which he ran on the side for a couple years, had a net return of 55% in 2004 and 61.9% in 2005. Nabi is also owned by Third Point LLC , another activist hedge fund founded by Daniel Loeb. The fund has had an average annual return of 28.9% since 1995. Two conferences are on the way in September and the company is selling its divisional assets. IMHO, probably the shorts will get squeezed soon.